Viatris Launches First National Direct to Consumer Campaign for Dry Eye Nasal Spray Tyrvaya
After nearly 2 years of educational programs to introduce Tyrvaya (varenicline solution) Nasal Spray to eye care professionals, the Viatris Eye Care Division announced it is rolling out a nationwide, multi-channel campaign. The new campaign, entitled “It’s Not Another Drop,” is directed to both consumers and eye care professionals, and depicts authentic experiences of patients managing dry eye disease. The campaign aims to makes patients aware of a different treatment option, Tyrvaya, to help motivate them to speak up and talk with their eye care professional.
In October 2021, Oyster Point Pharma received FDA approval for Tyrvaya (varenicline solution) the treatment of the signs and symptoms of dry eye disease. The approval marked the first and only nasal spray approved for the treatment of dry eye disease. In November 2022, Viatris announced a deal to acquire Oyster Point Pharma and establish it own eye care division.
In addition to its first national TV commercial for the brand, the new campaign also features numerous resources to help guide patients who may want to learn more about Tyrvaya that we thought would be of interest including:
- TYRVAYA.com
- How to Use TYRVAYA Video: a step-by-step guide on how to administer Tyrvaya
- Instructions for Use
- How TYRVAYA Works Video: A video to help you understand how Tyrvaya is believed to work
- Patient Savings and Support Brochure: an overview of how to save on Tyrvaya and more
- Doctor Discussion Guide: a guide to discuss your dry eye symptoms with your doctor and explore whether Tyrvaya is right for you